Company / EPS (Basic)
Haemonetics EPS (Basic) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.32
FY2026
5-year range
$0.85 / $2.32
FY2022-FY2026
Trend
+2.2%
vs FY2025
Sector context
#53 of 160
Health Care
What the data says
At $2.32, Haemonetics's eps (basic) ranks #53 of 160 in the Health Care sector. EPS (Basic) has fluctuated over the past 10 years, ranging from $-1.09 in FY2018 to $2.32 in FY2026.
Based on SEC 10-K filings.
2.32 in FY2026 with a 5-year CAGR of +22.2%.
Improved from $0.85 to $2.32 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
#53 of 160 in Health CareTop 33% of 160This company $2.32 Sector average $1.69
▼
+37.6% above sector average
Key checks
Key Insights
- In FY2026, eps (basic) increased 2.2% year-over-year.
- Ranks #53 out of 160 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2018.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.32 | +2.2% |
| FY2025 | $2.27 | +167.1% |
| FY2024 | $0.85 | -63.4% |
| FY2023 | $2.32 | +2.2% |
| FY2022 | $2.27 | +167.1% |
| FY2021 | $0.85 | -45.9% |
| FY2020 | $1.57 | +4.0% |
| FY2019 | $1.51 | +238.5% |
| FY2018 | -$1.09 | -430.3% |
| FY2017 | $0.33 | -51.5% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026